Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs directed at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where therapy choices remain limited. Use the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Examine Our Pipeline https://financefeeds.com/sifma-slams-previous-secs-aggressive-rulemaking-lays-out-2025-priorities/